课题基金 / 基金详情

RR&D Research Career Scientist Award Application

RR&D Research Career Scientist Award Application
RR
批准号:
10553600
负责人:
Machelle T. Pardue
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-01-01 至 2025-12-31

项目摘要

项目成果

Machelle T. Pardue的其他基金

相似基金

相关文献

中文摘要
翻译
Pardue博士的研究项目集中在为退伍军人开发改变生活的治疗方法, 视力丧失她在三个研究领域做出了重大贡献:a)视网膜病变的治疗 B)糖尿病视网膜病变的早期检测和治疗,和c)屈光不正的视网膜机制, 发展她的研究项目的临床前研究增强了我们对 致盲性疾病的潜在机制和先进的新治疗方案。她的双重身份 退伍军人事务部和格鲁吉亚理工学院创造了一个独特的局面,利用资源和合作, 技术进入临床。她坚信合作研究对于转化成果至关重要 从长凳到床边。这反映在她的89篇出版物中,有75%以上来自与 超过46个不同的调查员此外,她的研究结果形成了翻译研究的三个领域的基础 用于人类患者(视网膜修复、糖尿病视网膜病变和神经保护疗法)。帕杜医生的双胞胎 任命和研究兴趣创造了新的机会,绘制平行和交叉点之间 不同的系统和研究领域具有突破性发现的潜力。 帕杜博士对教学和指导的承诺体现在许多角色上。她有 在过去的18年里,我为本科生和研究生讲授视网膜和视觉系统, 曾任7门课程的讲师。Pardue博士对专业发展有着浓厚的兴趣, 在弗吉尼亚州、埃默里和格鲁吉亚州为博士后和研究生组织和教授有关这一主题的课程 技术,以及国际会议。此外,她积极支持妇女在科学 研究生和初级教师水平通过机构和国际计划。帕杜博士指导了5名 VA职业发展奖获得者(CDA)。她所指导的学生中,超过80%的人继续 在医学或科学上。 Pardue博士在她的职业生涯中一直为科学界服务。具体到退伍军人事务部, 博士Pardue于2004-2008年担任IACUC委员会主席,并在过去十年中担任研发委员会主席 年(2008年至今)。她协助亚特兰大退伍军人康复中心的两个成功的更新周期。为 科学项目副主任,她指导了所有康复中心的内部审查过程 提交,提高资助率为20%的优点和42%的CDA。她目前担任 CVNR的临时副主任。她还担任顾问委员会的亚特兰大弗吉尼亚州非营利组织 基金会(AREF)。在国际一级,她曾在ARVO的几个委员会任职, 于2016年5月荣获其著名的银奖。帕杜博士曾在许多研究部门任职 来自NIH,VA和各种国家和国际私人基金会。她目前担任一名 NIH神经科学和眼科成像技术(NOIT)研究部门成员。她的贡献 在该领域的领导地位在2017年被美国研究所的研究员所认可。 医学和生物工程师(AIMBE)。 Pardue博士的未来目标是:1)为致盲疾病制定新的康复策略,2)识别 糖尿病视网膜病变的早期症状,并确定早期干预措施,以减缓视力的进展 损失,和3)确定多巴胺在屈光性眼睛生长中的作用。这些目标是以结果为基础的 在过去的几年里,她的实验室,包括出版物的数量增加, 期刊基于先前的成功,她预计新的治疗策略的发展。翻译 这些发现从实验室到临床将通过她在CVNR内部的合作得到促进, 退伍军人事务部的临床医生因此,这些项目支持理解和治疗视网膜病变的共同主题, 疾病,以延长功能性视力和退伍军人管理局的使命,改善退伍军人的医疗保健。
英文摘要
Dr. Pardue’s research program is centered on developing life-changing treatments for veterans with vision loss. She has made significant contributions in three research areas: a) treatments for retinal degeneration, b) early detection and treatment of diabetic retinopathy, and c) retinal mechanisms of refractive development. Pre-clinical studies from her research program have enhanced our understanding of mechanisms that underlie blinding diseases and advanced new treatment options. Her dual position between the VA and Georgia Tech creates a unique situation to leverage resources and collaborations to move new technologies into the clinic. She is a firm believer that collaborative research is essential to translate results from bench to bedside. This is reflected in over 75% of her 89 publications stemming from collaborations with over 46 different investigators. Moreover, her findings have formed the basis for 3 areas of translational studies to human patients (retinal prosthetics, diabetic retinopathy, and neuroprotection therapies). Dr. Pardue’s dual appointment and research interests create novel opportunities to draw parallels and intersections between different systems and fields of study with the potential for ground-breaking discoveries. Dr. Pardue’s commitment to teaching and mentorship are illustrated by a number of roles. She has lectured to undergraduate and graduate students on the retina and visual system for the last 18 years and been the instructor for 7 courses. Dr. Pardue has a strong interest in professional development and has organized and taught courses for post-docs and graduate students on this topic at the VA, Emory, and Georgia Tech, as well as at international conferences. In addition, she actively supports women in science at the graduate and junior faculty levels through institutional and international programs. Dr. Pardue has mentored 5 VA Career Development Awardees (CDAs). Over 80% of the students that she has mentored have continued on in medicine or science. Dr. Pardue has consistently served the scientific community throughout her career. Specific to the VA, Dr. Pardue chaired the IACUC Committee from 2004-2008 and has chaired the R&D Committee for the last ten years (2008-date). She assisted with two successful renewal cycles of the Atlanta VA Rehab Center. As the Associate Director of Scientific Projects, she directed the internal review process of all Rehab Center submissions, increasing the funding rate to 20% for Merits and 42% for CDAs. She currently serves as the interim Associate Director of the CVNR. She also serves on the Advisory Board for the Atlanta VA non-profit foundation (AREF). On the international level, she has served on several committees for ARVO and was awarded their prestigious Silver Fellow Award in May 2016. Dr. Pardue has served on many study sections from NIH, VA, and various national and international private foundations. She currently serves as a regular member of NIH Neuroscience and Ophthalmic Imaging Technologies (NOIT) study section. Her contributions and leadership in the field was recognized in 2017 by induction as a fellow into the American Institute of Medical and Biological Engineers (AIMBE). Dr. Pardue’s future goals are to 1) develop new rehabilitation strategies for blinding diseases, 2) identify the earliest signs of diabetic retinopathy and determine early interventions to slow the progression of vision loss, and 3) determine the role of dopamine in refractive eye growth. These goals are grounded in the results from her laboratory over the last several years, including the increased number of publications in high impact journals. Based on prior success, she anticipates the development of new treatment strategies. Translation of these findings from the laboratory to the clinic will be facilitated by her collaborations within the CVNR and clinicians at the VA. Thus, these projects support both the common theme of understanding and treating retinal disease to prolong functional vision and the VA mission of improving healthcare for veterans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treating early stage diabetic retinopathy
  • 批准号:
    10656335
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    Machelle T. Pardue
  • 依托单位:
ShEEP Request for Confocal Microscope
  • 批准号:
    10179606
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Machelle T. Pardue
  • 依托单位:
RR&D Research Career Scientist Award Application
  • 批准号:
    10382219
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Machelle T. Pardue
  • 依托单位:
Detecting Early Stage Diabetic Retinopathy
  • 批准号:
    9108877
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Machelle T. Pardue
  • 依托单位:
海外基金